Helix Launches Advanced CDM & Pharmacovigilance Courses Worldwide

Press Release (ePRNews.com) - LONDON, England - Feb 17, 2016 - Being one of the leader in conducting Clinical Research Professional Development Programs in the ICH and Non ICH regions for over 15 years in ICH and Non ICH regions ,the Founder of UK based MNC,Helix Research Center Ltd has decided to launch advanced Training for the Clinical Data Management(CDM) & Pharmacovigilance (PV)Professionals working with leading Contract Research Organisations (CROs) and BPOs in Europe,Africa,CIS,MENA,Asia Pacific,South/Central America ,Caribbean ,US,Canada Mexico .

The Trainers of Team of Helix Research Center Ltd consists of expeienced Professionals with over 15 years of experience in Clinical Data Management & Pharmacovigilance services & most of them are World’s Who is WHO in their areas of expertise .The Avanced CDM and PV Training includes training in Oracle Clinical and Argus Softwares respectively and mode of deliery of the Training is Online and Onsite .Helix is keen to conduct Corporate Training ,rather than just for Individual Professionals .Inorder to conduct Online or inclass Training ,a group of 20 participants is a must and the course fee ranges from USD 500 to 3000 per candidate .

Helix is also conducting advanced Good Clinical Practices,Good Laboratory Practices and Good Manufacturing Practices Training for the Global Pharmaceutical Industry and Inspectors of Regulatory Authorities in non ICH region.

Helix is actively promoting Continuing Medical Education and Evidence based Medicine ,especilly for the Healthcare Professionals working  in remote areas through webinars .

Helix is keen to explore Public Private Partnerships to Promote Vocational Education to create more jobs in the developing World

Source : Helix Research Center Ltd

You may also like this  



Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.